Nu Skin Enterprises, Inc.
NUS
$6.55
-$0.08-1.21%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.44B | 1.49B | 1.56B | 1.63B | 1.68B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.44B | 1.49B | 1.56B | 1.63B | 1.68B |
| Cost of Revenue | 442.38M | 453.76M | 473.03M | 494.22M | 505.72M |
| Gross Profit | 998.90M | 1.03B | 1.09B | 1.13B | 1.17B |
| SG&A Expenses | 917.37M | 940.52M | 988.14M | 1.04B | 1.08B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.36B | 1.39B | 1.46B | 1.53B | 1.59B |
| Operating Income | 81.53M | 90.88M | 99.23M | 95.82M | 88.83M |
| Income Before Tax | 64.20M | 196.20M | 120.20M | 117.51M | -41.55M |
| Income Tax Expenses | 9.67M | 35.99M | 10.60M | 16.68M | -3.01M |
| Earnings from Continuing Operations | 54.53 | 160.20 | 109.61 | 100.83 | -38.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.53M | 160.20M | 109.61M | 100.83M | -38.55M |
| EBIT | 81.53M | 90.88M | 99.23M | 95.82M | 88.83M |
| EBITDA | 131.93M | 143.14M | 155.03M | 156.85M | 154.41M |
| EPS Basic | 1.11 | 3.23 | 2.21 | 2.03 | -0.78 |
| Normalized Basic EPS | 1.19 | 1.28 | 1.74 | 1.35 | 0.87 |
| EPS Diluted | 1.09 | 3.19 | 2.18 | 2.01 | -0.80 |
| Normalized Diluted EPS | 1.18 | 1.27 | 1.73 | 1.35 | 0.87 |
| Average Basic Shares Outstanding | 195.62M | 197.18M | 198.32M | 198.62M | 198.87M |
| Average Diluted Shares Outstanding | 199.14M | 200.05M | 199.85M | 199.27M | 199.46M |
| Dividend Per Share | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
| Payout Ratio | 21.47% | 7.39% | 10.87% | 11.83% | -31.00% |